Microparticles during long-term follow-up after acute myocardial infarction

Summary

Microparticles (MPs) are formed from platelets (PMPs), endothelial cells (EMPs) and monocytes (MMPs), and in acute myocardial infarction (MI), there is an increase of MPs in the culprit artery. In this study MPs were evaluated in whole blood in 105 patients with MI at five time-points during a two-year follow-up (FU). Patients with non-ST-elevated MI had higher concentrations of CD41+MPs compared to ST-elevated MI patients (p=0.024). The concentrations of PMPs in whole blood increased during the time period (p<0.001), but no significant change over time was found for EMPs and MMPs. CD62P+MP counts were higher in MI patients with diabetes (p=0.020), and patients with hypertension had increased levels of CD14+MPs (p=0.004). The amount of CD62P+TF+MPs increased significantly during FU (p<0.001). Patients with atherosclerosis in three arterial beds, i. e. coronary, carotid and peripheral arteries, had lower concentrations of CD62P+TF+MPs (p=0.035) and CD144+TF+MPs (p=0.004) compared to patients with atherosclerosis in one or two arterial beds. Higher concentrations of CD62P+MPs early after MI were associated with an increased risk of cardiovascular events during FU, hazard ratio 3.32 (95%CI1.20–9.31). Only small variations in PMP, EMP and MMP concentrations were found during long-term FU after MI and their levels seem to reflect the underlying cardiovascular disease rather than the acute MI. PMPs expressing P-selectin might be a promising biomarker for predicting future cardiovascular events, but further studies are needed to confirm these results.

Supplementary Material to this article is available online at www.thrombosis-online.com.

Keywords

P-selectin - tissue factor - atherosclerosis - platelets - endothelial cells

• References

• 1 Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 2013; 200: 373-383.
• 2 Yanez-Mo M, Siljander PR, Andreu Z. et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 2015; 04: 27066.
• 3 Zhang C, Yang Y. Microparticles are the basic storage units for different proteins in platelet granules. Blood 2012; (Retraction published in Blood 2013; 121 3298
• 4 Das S, Halushka MK. Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol 2015; 24: 199-206.
• 5 Habersberger J, Strang F, Scheichl A. et al. Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction. Cardiovasc Res 2012; 96: 64-72.
• 6 Horn P, Cortese-Krott MM, Amabile N. et al. Circulating microparticles carry a functional endothelial nitric oxide synthase that is decreased in patients with endothelial dysfunction. J Am Heart Assoc 2013; 02: e003764.
• 7 Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-949.
• 8 Blann A, Shantsila E, Shantsila A. Microparticles and arterial disease. Semin Thromb Hemost 2009; 35: 488-496.
• 9 Mallat Z, Hugel B, Ohan J. et al. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-353.
• 10 Lacroix R, Robert S, Poncelet P. et al. Overcoming limitations of microparticle measurement by flow cytometry. Semin Thromb Hemost 2010; 36: 807-818.
• 11 Ayers L, Nieuwland R, Kohler M. et al. Dynamic microvesicle release and clearance within the cardiovascular system: triggers and mechanisms. Clin Sci 2015; 129: 915-931.
• 12 Min PK, Kim JY, Chung KH. et al. Local increase in microparticles from the aspirate of culprit coronary arteries in patients with ST-segment elevation myocardial infarction. Atherosclerosis 2013; 227: 323-328.
• 13 Porto I, Biasucci LM, De Maria GL. et al. Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention. Eur Heart J 2012; 33: 2928-2938.
• 14 Boulanger CM, Scoazec A, Ebrahimian T. et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104: 2649-2652.
• 15 Bulut D, Tuns H, Mugge A. CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease. Eur J Clin Invest 2009; 39: 17-22.
• 16 Rognoni A, Cavallino C, Lupi A. et al. Novel biomarkers in the diagnosis of acute coronary syndromes: the role of circulating miRNAs. Expert Rev Cardiovasc Ther 2014; 12: 1119-1124.
• 17 Lacroix R, Judicone C, Mooberry M. et al. Standardisation of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis Haemostasis SSC Collaborative workshop. J Thromb Haemost 2013; 11: 1190-1193.
• 18 Shah MD, Bergeron AL, Dong JF. et al. Flow cytometric measurement of micro-particles: pitfalls and protocol modifications. Platelets 2008; 19: 365-372.
• 19 van Ierssel SH, Van Craenenbroeck EM, Conraads VM. et al. Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied. Thrombosis Res 2010; 125: 332-339.
• 20 Christersson C, Johnell M, Siegbahn A. Evaluation of microparticles in whole blood by multicolour flow cytometry assay. Scand J Clin Lab Invest 2013; 73: 229-239.
• 21 Jung C, Sorensson P, Saleh N. et al. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis 2012; 221: 226-231.
• 22 Mallat Z, Benamer H, Hugel B. et al. Elevated levels of shed membrane micro-particles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841-843.
• 23 Morel O, Pereira B, Averous G. et al. Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Atherosclerosis 2009; 204: 636-641.
• 24 Morel O, Hugel B, Jesel L. et al. Sustained elevated amounts of circulating procoagulant membrane microparticles and soluble GPV after acute myocardial infarction in diabetes mellitus. Thromb Haemost 2004; 91: 345-353.
• 25 Suades R, Padro T, Vilahur G. et al. Growing thrombi release increased levels of CD235a microparticles and decreased levels of activated platelet-derived micro particles. Validation in ST-elevation myocardial infarction patients. J Thromb Haemost 2015; 13: 1776-1786.
• 26 Horn P, Baars T, Kahlert P. et al. Release of Intracoronary Microparticles during Stent Implantation into Stable Atherosclerotic Lesions under Protection with an Aspiration Device. PLoS One 2015; 10: e0124904.
• 27 Zeiger F, Stephan S, Hoheisel G. et al. P- Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease. Blood Coagul Fibrinolysis 2000; 11: 723-728.
• 28 van der Zee PM, Biro E, Ko Y. et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myo-cardial infarction. Clin Chem 2006; 52: 657-664.
• 29 Christersson C, Johnell M, Siegbahn A. Tissue factor and IL8 production by P-selectin-dependent platelet-monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10. J Thromb Haemost 2008; 06: 986-994.
• 30 Evangelista V, Manarini S, Sideri R. et al. Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood 1999; 93: 876-885.
• 31 Falati S, Liu Q, Gross P. et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197: 1585-1598.
• 32 Wang HB, Wang JT, Zhang L. et al. P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol 2007; 08: 882-892.
• 33 Morel O, Morel N, Freyssinet JM. et al. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 2008; 19: 9-23.
• 34 Nomura S, Inami N, Shouzu A. et al. Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus. Platelets 2009; 20: 406-414.
• 35 Zhang X, McGeoch SC, Johnstone AM. et al. Platelet-derived microparticle count and surface molecule expression differ between subjects with and without type 2 diabetes, independently of obesity status. J Thromb Thrombolysis 2014; 37: 455-463.
• 36 Almquist T, Mobarrez F, Jacobson SH. et al. Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease. Nephrol Dial Transplant 2016; 31: 944-952.
• 37 Aberg M, Eriksson O, Siegbahn A. Tissue Factor Noncoagulant Signaling: Mechanisms and Implications for Cell Migration and Apoptosis. Semin Thromb Hemost 2015; 41: 691-699.
• 38 Amabile N, Cheng S, Renard JM. et al. Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. Eur Heart J 2014; 35: 2972-2979.
• 39 Koga H, Sugiyama S, Kugiyama K. et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2005; 45: 1622-1630.
• 40 Preston RA, Jy W, Jimenez JJ. et al. Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003; 41: 211-217.
• 41 Montoro-Garcia S, Shantsila E, Tapp LD. et al. Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes. Atherosclerosis 2013; 227: 313-322.
• 42 Radecke CE, Warrick AE, Singh GD. et al. Coronary artery endothelial cells and microparticles increase expression of VCAM-1 in myocardial infarction. Thromb Haemost 2015; 113: 605-616.
• 43 Cui Y, Zheng L, Jiang M. et al. Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein. Mol Biol Rep 2013; 40: 6437-6442.
• 44 Suades R, Padro T, Crespo J. et al. Circulating microparticle signature in coronary and peripheral blood of ST elevation myocardial infarction patients in relation to pain-to-PCI elapsed time. Int J Cardiol 2016; 202: 378-387.
• 45 Hoyer FF, Giesen MK, Nunes Franca C. et al. Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice. J Cell Mol Med 2012; 16: 2777-2788.